Carlos Alban Spring Works Therapeutics, Inc. (SWTX) insider trading activity

SWTX Quotes by TradingView

Carlos Alban is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 18,801 shares of SWTX, which is worth approximately $728,538. The most recent transaction as insider was on May 16, 2024, when has been sold 4,095 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8K
0% 3M change
27.85% 12M change
Total Value Held $728,538

CARLOS ALBAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
BUY
Grant, award, or other acquisition
-
4,095 Added 17.89%
18,801 Common Stock
May 24 2023
BUY
Grant, award, or other acquisition
-
4,648 Added 24.02%
14,706 Common Stock
Jul 14 2022
BUY
Grant, award, or other acquisition
-
10,058 Added 50.0%
10,058 Common Stock

Also insider at

ABBV
AbbVie Inc. Healthcare
Vice Chairman
SOLV
Solventum Corp
Director
CA

Carlos Alban

Director
North Chicago, IL

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SWTX